Promoter variants of KIR2DL5 add to diversity and may impact gene expression

Immunogenetics

Volumn 60, Issue 6, 2008, Pages 287-294

  Mulrooney, Tiernan J ^a   Hou, LiHua ^a   Steiner, Noriko K ^a   Chen, Minghua ^a   Belle, Ian ^a   Ng, Jennifer ^a   Hurley, Carolyn Katovich ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Immune receptor; Immunogenetics; Natural killer cell

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ALLELE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE LOCUS; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ALLELES; BASE SEQUENCE; GENE EXPRESSION; GENETIC VARIATION; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; RECEPTORS, KIR2DL5;

EID: 44449123758     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-008-0273-7     Document Type: Article

References (26)

1. Davies GE, Locke SM, Wright PW, Li H, Hanson RJ, Miller JS, Anderson SK (2007) Identification of bidirectional promoters in the human KIR genes. Genes Immun 8:245-253
2. Estefania E, Flores R, Gomez-Lozano N, Aguilar H, Lopez-Botet M, Vilches C (2007) Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets. J Immunol 178:4402-4410
3. Gardiner CM, Guethlein LA, Shilling HG, Pando M, Carr WH, Rajalingam R, Vilches C, Parham P (2001) Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 166:2992-3001
4. Gedil MA, Steiner NK, Hurley CK (2007) KIR3DL2: diversity in a hematopoietic stem cell transplant population. Tissue Antigens 70:228-232
5. Gomez-Lozano N, Vilches C (2002) Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update. Tissue Antigens 59:184-193
6. Gomez-Lozano N, Gardiner CM, Parham P, Vilches C (2002) Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. Immunogenetics 54:314-319
7. Gomez-Lozano N, Estefania E, Williams F, Halfpenny I, Middleton D, Solis R, Vilches C (2005) The silent KIR3DP1 gene (CD158c) is transcribed and might encode a secreted receptor in a minority of humans, in whom the KIR3DP1, KIR2DL4 and KIR3DL1/KIR3DS1 genes are duplicated. Eur J Immunol 35:16-24
8. Gomez-Lozano N, Trompeter HI, de Pablo R, Estefania E, Uhrberg M, Vilches C (2007) Epigenetic silencing of potentially functional KIR2DL5 alleles: implications for the acquisition of KIR repertoires by NK cells. Eur J Immunol 37:1954-1965
9. Hou L, Chen M, Steiner NK, Belle I, Turino C, Ng J, Hurley CK (2007a) Seventeen novel alleles add to the already extensive KIR3DL3 diversity. Tissue Antigens 70(6):449-454
10. Hou LH, Steiner NK, Chen M, Belle I, Ng J, Hurley CK (2007b) KIR2DL1 allelic diversity: four new alleles characterized in a bone marrow transplant population and three families. Tissue Antigens 69:250-254
11. Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B (2002) Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 169:5118-5129
12. Marsh SGE, Parham P, Dupont B, Geraghty DE, Trowsdale J, Middleton D, Vilches C, Carrington M, Witt C, Guethlein LA, Shilling H, Garcia CA, Hsu KC, Wain H (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Tissue Antigens 62:79-86
13. Middleton D, Meenagh A, Gourraud PA (2007) KIR haplotype content at the allele level in 77 Northern Irish families. Immunogenetics 59:145-158
14. Ponti C, Gibellini D, Boin F, Melloni E, Manzoli FA, Cocco L, Zauli G, Vitale M (2002) Role of CREB transcription factor in c-fos activation in natural killer cells. Eur J Immunol 32:3358-3365
15. Presnell SR, Zhang L, Ramilo CA, Chan HW, Lutz CT (2006) Functional redundancy of transcription factor-binding sites in the killer cell Ig-like receptor (KIR) gene promoter. Int Immunol 18:1221-1232
16. Robinson J, Waller MJ, Stoehr P, Marsh SG (2005) IPD-the immuno polymorphism database. Nucleic Acids Res 33:D523-D526
17. Shulse C, Steiner NK, Hurley CK (2007) Allelic diversity in KIR2DL4 in a bone marrow transplant population: description of three novel alleles. Tissue Antigens 70:157-159
18. Stewart CA, van Bergen J, Trowsdale J (2003) Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters. J Immunol 170:6073-6081
19. Trompeter HI, Gomez-Lozano N, Santourlidis S, Eisermann B, Wernet P, Vilches C, Uhrberg M (2005) Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3. J Immunol 174:4135-4143
20. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, Tyan D, Lanier LL, Parham P (1997) Human diversity in killer cell inhibitory receptor genes. Immunity 7:753-763
21. van Bergen J, Stewart CA, van den Elsen PJ, Trowsdale J (2005) Structural and functional differences between the promoters of independently expressed killer cell Ig-like receptors. Eur J Immunol 35:2191-2199
22. Vilches C, Gardiner CM, Parham P (2000a) Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. J Immunol 165:6416-6421
23. Vilches C, Rajalingam R, Uhrberg M, Gardiner CM, Young NT, Parham P (2000b) KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains. J Immunol 164:5797-5804
24. Xu J, Vallejo AN, Jiang Y, Weyand CM, Goronzy JJ (2005) Distinct transcriptional control mechanisms of killer immunoglobulin-like receptors in natural killer (NK) and in T Cells. J Biol Chem 280:24277-24285
25. Yawata M, Yawata N, Draghi M, Little AM, Partheniou F, Parham P (2006) Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 203:633-645
26. Yusa S, Catina TL, Campbell KS (2004) KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2). J Immunol 172:7385-7392